Skip to content

A randomised controlled trial testing the effect of counselling via Zoom upon intake of iron and folic acid supplements, diets, and antenatal care in pregnancy in the rural plains of Nepal

Virtual Antenatal Intervention for improved Diet and Iron intake (VALID): A randomized controlled trial in Kapilbastu district, Nepal

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17842200
Enrollment
300
Registered
2022-01-13
Start date
2022-01-14
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of iron deficiency anaemia during pregnancy Pregnancy and Childbirth

Interventions

Tailored virtual counselling will be conducted with pregnant women and their families by nutrition assistants (NAs) using zoom (or similar) video conferencing on tablets containing SIM cards that have

Sponsors

HERD International
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Pregnant girl/woman aged between 13 to 49 years 2. Able to respond to questions 3. Resident of study cluster (whether at husband’s or parental home) 4. Less than or equal to 28 weeks’ gestation estimated from recall of last menstrual period (or expected date of delivery given by a health worker) 5. Plans not to leave the country during the follow-up period 5 weeks since enrolment 6. Does not have another pregnant woman in her household already enrolled in the trial 7. Consents to participate in the trial

Exclusion criteria

Exclusion criteria: 1. Aged =50 years 2. Not-consenting to participate in the trial 3. Unable to respond to questions 4. =28 weeks’ gestation at enrolment as estimated from LMP (or expected date of delivery given by a health worker) 5. Planning to leave the country during follow up period. 6. Has another pregnant woman in her household already enrolled in the trial

Design outcomes

Primary

MeasureTime frame
The proportion of pregnant women consuming IFA on at least 80% of the days (i.e. on 12 or more days out of 14 days recalled) at endline interview which will be at least two weeks after the second virtual counselling session (17-36 weeks’ gestation).

Secondary

MeasureTime frame
All secondary outcomes will be recalled by trial participants during face-to-face or telephone interviews and recorded in electronic questionnaires collected at endline: 1. Count of Antenatal (ANC) visits between enrolment and endline interview 2. 24 hour Women’s Diet Diversity Score collected using the women’s dietary diversity score updated 2021 tool collected at endline (mean per arm) 3. Consumption of intervention-promoted foods (green leafy veg with lemon, organ meat or and meat/fish) in the 24 hours preceding the endline interview. 4. Practicing ways to enhance bioavailability in the 7 days preceding the at endline questionnaire. This will be scored as 1 if the pregnant woman reports having done any of the following in the previous 7 days and will otherwise be scored as 0: - using lemon or other vitamin C-rich foods with meals, - eating sprouted grains or pulses, - avoiding tea/coffee 1 hr either side of meals, - spreading meat-eating over two eating occasions rather than one. 5. Knowledge of iron-rich foods: a count of the number of iron-rich food groups correctly recalled at the endline interview. Exploratory outcomes on the impact pathway: 1. Timing of first ANC (in completed months’ gestation) – collected at baseline if ANC has been initiated, otherwise collected at endline. 2. Timing of first IFA (in completed weeks’ gestation) – collected at baseline if ANC has been initiated, otherwise collected at endline. 3. Quality of Antenatal care received between baseline and endline. This will comprise a score constructed from recall of advice received, measurement of height/ weight/ blood pressure/ fetal heartbeat, tetanus vaccination, deworming tablet receipt/intake, blood and urine tests, checking position of the baby). Data will be collected at endline. 4. Understanding of why blood tests are taken at antenatal check-ups. Measured as the proportion of women who had a blood test at their ANC visits who could correctly explain one or more reason for ha

Countries

Nepal

Contacts

Public ContactSanju Bhattarai
sanju.bhattarai@herdint.com+977 985-1055424

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 10, 2026